nifedipine has been researched along with Diabetes Mellitus in 24 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the impact of treatment on cardiovascular mortality and morbidity, we assessed outcomes in patients with hypertension and diabetes who received co-amilozide or nifedipine in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension." | 9.10 | Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT). ( Brown, M; Castaigne, A; de Leeuw, P; Mancia, G; Palmer, CR; Rosenthal, T; Ruilope, LM; Wagener, G, 2003) |
| "This study aimed to evaluate the efficacy of nifedipine controlled-release tablets combined with sacubitril valsartan in diabetic nephropathy (DN) patients with hypertension." | 8.31 | Therapeutic improvements of nifedipine controlled-release tablets combined with sacubitril valsartan on patients with diabetic nephropathy complicated with hypertension. ( Hu, L; Liu, G; Wei, Y, 2023) |
| "To investigate the impact of treatment on cardiovascular mortality and morbidity, we assessed outcomes in patients with hypertension and diabetes who received co-amilozide or nifedipine in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension." | 5.10 | Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT). ( Brown, M; Castaigne, A; de Leeuw, P; Mancia, G; Palmer, CR; Rosenthal, T; Ruilope, LM; Wagener, G, 2003) |
| "The effects of nisoldipine and slow release nifedipine on mild to moderate hypertension and glycaemic control were studied in 28 diabetic hypertensives, all except one of whom were non-insulin dependent." | 5.07 | Nifedipine and nisoldipine in hypertensive diabetics. ( Clarke, CW; Kubik, MM, 1991) |
| "This study aimed to evaluate the efficacy of nifedipine controlled-release tablets combined with sacubitril valsartan in diabetic nephropathy (DN) patients with hypertension." | 4.31 | Therapeutic improvements of nifedipine controlled-release tablets combined with sacubitril valsartan on patients with diabetic nephropathy complicated with hypertension. ( Hu, L; Liu, G; Wei, Y, 2023) |
| "Atenolol treatment significantly increased triglyceride levels and decreased the HDL-cholesterol levels after 9 months in both groups." | 2.68 | Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects. ( Goyal, RK; Satia, MC; Shukla, ML, 1995) |
| " In fact, there is a low possibility to derange the balance between insulin and glucagon secretion after acute and chronic administration of CEBs at conventional dosages." | 2.37 | [Effects of calcium antagonist drugs on glucide metabolism]. ( Gusmini, G; Lombardi, C; Rangoni, G; Spedini, C, 1988) |
| "Does nifedipine treatment slow down the progression of coronary calcification in diabetic patients? If the answer is yes, is this beneficial effect of nifedipine superior to that of other DHPs with equihypotensive properties? Does nifedipine treatment decrease expression levels of AGEs and RAGE in diabetic atherosclerosis? Is the unique effect of nifedipine on vascular calcification correlated with its AGE or RAGE-suppressing properties? These prospective studies will provide further valuable information whether nifedipine could prevent vascular calcification in diabetic atherosclerosis by blockade the AGE-RAGE signaling in vascular wall cells." | 1.34 | Prevention of diabetic vascular calcification by nifedipine, a dihydropyridine-based calcium channel blocker. ( Matsui, T; Nakamura, K; Yamagishi, S, 2007) |
| "Nifedipine was the most frequently prescribed antihypertensive (44." | 1.32 | Inadequate control of blood pressure in Nigerians with diabetes. ( Okoro, EO; Oyejola, BA, 2004) |
| " When used in standard recommended oral dosage nifedipine has no significant effect on glucose tolerance." | 1.26 | Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients. ( Donnelly, T; Harrower, AD, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wei, Y | 1 |
| Hu, L | 1 |
| Liu, G | 1 |
| West, HL | 1 |
| Corbin, KL | 1 |
| D'Angelo, CV | 1 |
| Donovan, LM | 1 |
| Jahan, I | 1 |
| Gu, G | 1 |
| Nunemaker, CS | 1 |
| Mancia, G | 1 |
| Brown, M | 1 |
| Castaigne, A | 1 |
| de Leeuw, P | 1 |
| Palmer, CR | 1 |
| Rosenthal, T | 1 |
| Wagener, G | 1 |
| Ruilope, LM | 1 |
| Okoro, EO | 1 |
| Oyejola, BA | 1 |
| Yoshida, D | 1 |
| Higashiura, K | 1 |
| Shimamoto, K | 1 |
| Yamagishi, S | 1 |
| Matsui, T | 1 |
| Nakamura, K | 1 |
| Trost, BN | 1 |
| Weidmann, P | 1 |
| Altura, BM | 1 |
| Altura, BT | 1 |
| Bhatnagar, SK | 1 |
| Amin, MM | 1 |
| Al-Yusuf, AR | 1 |
| Abadie, E | 1 |
| Gauville, C | 1 |
| Brisson, C | 1 |
| Donnelly, T | 1 |
| Harrower, AD | 1 |
| Giugliano, D | 1 |
| Torella, R | 1 |
| Cacciapuoti, F | 1 |
| Gentile, S | 1 |
| Verza, M | 1 |
| Varricchio, M | 1 |
| Cicco, G | 1 |
| Pirrelli, A | 1 |
| Satia, MC | 1 |
| Shukla, ML | 1 |
| Goyal, RK | 1 |
| Haller, H | 1 |
| Petralito, A | 1 |
| Lunetta, M | 1 |
| Liuzzo, A | 1 |
| Fiore, CE | 1 |
| Mangiafico, RA | 1 |
| Gill, J | 1 |
| Fonseca, V | 1 |
| Dandona, P | 1 |
| Jeremy, JY | 1 |
| Preobrazhenskiĭ, DV | 1 |
| Fomichev, VI | 1 |
| Afanas'ev, AIa | 1 |
| Ferder, L | 1 |
| Daccordi, H | 1 |
| Martello, M | 1 |
| Panzalis, M | 1 |
| Inserra, F | 1 |
| Clarke, CW | 1 |
| Kubik, MM | 1 |
| Gusmini, G | 1 |
| Lombardi, C | 1 |
| Rangoni, G | 1 |
| Spedini, C | 1 |
| Benaim, ME | 1 |
| Macdonald, G | 1 |
| Kendall, MJ | 1 |
| Horton, RC | 1 |
| Chellingsworth, MC | 1 |
7 reviews available for nifedipine and Diabetes Mellitus
| Article | Year |
|---|---|
[Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2005 |
Effects of nitrendipine and other calcium antagonists on glucose metabolism in man.
Topics: Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus; Glucose; Glucose Tolerance Test; Glycate | 1984 |
Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Topics: Anesthesia; Animals; Arterioles; Blood Pressure; Calcium; Calcium Channel Blockers; Cell Membrane Pe | 1984 |
Endothelial function. General considerations.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Capillary Permeability; Diabetes Mellitus; Endo | 1997 |
[Effects of calcium antagonists on carbohydrate and lipid metabolism].
Topics: Animals; Calcium Channel Blockers; Carbohydrate Metabolism; Cholesterol; Coronary Disease; Diabetes | 1992 |
[Effects of calcium antagonist drugs on glucide metabolism].
Topics: Animals; Calcium Channel Blockers; Diabetes Mellitus; Female; Glucagon; Glucose; Glucose Tolerance T | 1988 |
Calcium antagonists and glycaemic control.
Topics: Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus; Diltiazem; Glucose Tolerance Test; Human | 1986 |
7 trials available for nifedipine and Diabetes Mellitus
| Article | Year |
|---|---|
Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).
Topics: Aged; Amiloride; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular D | 2003 |
Impairment of insulin secretion in man by nifedipine.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Female; Glucose Tolerance Test; Humans; Insulin; Insu | 1980 |
Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects.
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Creatin | 1995 |
Lisinopril and nifedipine administration inhibits the ex vivo uptake of [45Ca2+] by platelets from hypertensive diabetic patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Platelets; Bucladesine; Calcium; Diabet | 1992 |
Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Creatinine; Diab | 1992 |
Nifedipine and nisoldipine in hypertensive diabetics.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Humans; Hyper | 1991 |
Effect of nifedipine on carbohydrate metabolism and serum lipoproteins in hypertensive patients with and without diabetes mellitus.
Topics: Adult; Aged; Blood Pressure; Carbohydrate Metabolism; Diabetes Complications; Diabetes Mellitus; Fem | 1987 |
10 other studies available for nifedipine and Diabetes Mellitus
| Article | Year |
|---|---|
Therapeutic improvements of nifedipine controlled-release tablets combined with sacubitril valsartan on patients with diabetic nephropathy complicated with hypertension.
Topics: Biphenyl Compounds; Delayed-Action Preparations; Diabetes Mellitus; Diabetic Nephropathies; Drug Com | 2023 |
Postnatal maturation of calcium signaling in islets of Langerhans from neonatal mice.
Topics: Aging; Animals; Animals, Newborn; Calcium; Calcium Channels, L-Type; Calcium Signaling; Diabetes Mel | 2021 |
Inadequate control of blood pressure in Nigerians with diabetes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Angiotensin-Converting Enzym | 2004 |
Prevention of diabetic vascular calcification by nifedipine, a dihydropyridine-based calcium channel blocker.
Topics: Calcinosis; Calcium Channel Blockers; Diabetes Mellitus; Dihydropyridines; Humans; Models, Biologica | 2007 |
Diabetogenic effects of nifedipine.
Topics: Aged; Blood Glucose; Diabetes Mellitus; Humans; Hypertension; Male; Middle Aged; Nifedipine | 1984 |
Diabetogenic effects of nifedipine.
Topics: Diabetes Mellitus; Humans; Hyperglycemia; Nifedipine | 1984 |
Nifedipine and endocrine status in diabetic patients.
Topics: Adult; Aged; Diabetes Mellitus; Growth Hormone; Humans; Middle Aged; Nifedipine | 1984 |
Effect of nifedipine on glucose tolerance and insulin secretion in diabetic and non-diabetic patients.
Topics: Adult; Aged; Angina Pectoris; Blood Glucose; Diabetes Mellitus; Female; Glucose Tolerance Test; Huma | 1980 |
[Glyco-lipid changes in hypertensive diabetic patients undergoing treatment with nifedipine and captopril].
Topics: Adult; Blood Glucose; Captopril; Cholesterol; Diabetes Complications; Diabetes Mellitus; Follow-Up S | 1993 |
[Influence of nifedipine on the curve of the glucose tolerance test in normal subjects and in subjects with altered carbohydrate metabolism].
Topics: Adult; Aged; Blood Glucose; Calcium; Carbohydrate Metabolism; Diabetes Mellitus; Glucose Tolerance T | 1979 |